Newer antihistaminic agents

Research output: Contribution to journalArticle

Abstract

Two new antihistamines with properties different from those of currently available drugs are nearing licensure. Named terfenidine and astemizole, they are almost exclusively H1-antagonists, lacking anticholinergic and sympathetic activity. They fail to penetrate the central nervous system and lack sedative effects. They are long-acting and require less frequent doses. Thus they allow sustained antihistaminic action without the usual side effects.

Original languageEnglish (US)
Pages (from-to)366-368
Number of pages3
JournalThe Journal of Allergy and Clinical Immunology
Volume76
Issue number2 PART 2
DOIs
StatePublished - 1985

Fingerprint

Astemizole
Terfenadine
Histamine Antagonists
Cholinergic Antagonists
Licensure
Hypnotics and Sedatives
Central Nervous System
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Newer antihistaminic agents. / Norman, Philip S.

In: The Journal of Allergy and Clinical Immunology, Vol. 76, No. 2 PART 2, 1985, p. 366-368.

Research output: Contribution to journalArticle

@article{3491d0b0ae394677847f92c0c81e9002,
title = "Newer antihistaminic agents",
abstract = "Two new antihistamines with properties different from those of currently available drugs are nearing licensure. Named terfenidine and astemizole, they are almost exclusively H1-antagonists, lacking anticholinergic and sympathetic activity. They fail to penetrate the central nervous system and lack sedative effects. They are long-acting and require less frequent doses. Thus they allow sustained antihistaminic action without the usual side effects.",
author = "Norman, {Philip S.}",
year = "1985",
doi = "10.1016/0091-6749(85)90655-4",
language = "English (US)",
volume = "76",
pages = "366--368",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2 PART 2",

}

TY - JOUR

T1 - Newer antihistaminic agents

AU - Norman, Philip S.

PY - 1985

Y1 - 1985

N2 - Two new antihistamines with properties different from those of currently available drugs are nearing licensure. Named terfenidine and astemizole, they are almost exclusively H1-antagonists, lacking anticholinergic and sympathetic activity. They fail to penetrate the central nervous system and lack sedative effects. They are long-acting and require less frequent doses. Thus they allow sustained antihistaminic action without the usual side effects.

AB - Two new antihistamines with properties different from those of currently available drugs are nearing licensure. Named terfenidine and astemizole, they are almost exclusively H1-antagonists, lacking anticholinergic and sympathetic activity. They fail to penetrate the central nervous system and lack sedative effects. They are long-acting and require less frequent doses. Thus they allow sustained antihistaminic action without the usual side effects.

UR - http://www.scopus.com/inward/record.url?scp=0022384599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022384599&partnerID=8YFLogxK

U2 - 10.1016/0091-6749(85)90655-4

DO - 10.1016/0091-6749(85)90655-4

M3 - Article

C2 - 2862177

AN - SCOPUS:0022384599

VL - 76

SP - 366

EP - 368

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2 PART 2

ER -